clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03269669 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2022-12-31 | |
P1050 | medical condition | lymphoma | Q208414 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 150 | |
P4844 | research intervention | doxorubicin | Q18936 |
obinutuzumab | Q389496 | ||
(RS)-cyclophosphamide | Q408524 | ||
vincristine | Q408977 | ||
rituximab | Q412323 | ||
prednisone | Q424972 | ||
bendamustine hydrochloride | Q27272066 | ||
Caelyx | Q29004943 | ||
(RS)-lenalidomide | Q425681 | ||
P6153 | research site | University of Chicago | Q131252 |
Yale University | Q49112 | ||
University of Rochester | Q149990 | ||
Ohio State University | Q309331 | ||
University of Michigan | Q230492 | ||
University of Washington | Q219563 | ||
Northwestern University | Q309350 | ||
Roswell Park Comprehensive Cancer Center | Q7370121 | ||
Saint Luke's Hospital | Q7401747 | ||
Swedish Medical Center | Q7654755 | ||
University Medical Center of Southern Nevada | Q7894830 | ||
University of Nebraska Medical Center | Q7895888 | ||
University of Oklahoma Health Sciences Center | Q7896014 | ||
Washington University School of Medicine | Q7972509 | ||
Wesley Medical Center | Q7983961 | ||
Helen DeVos Children's Hospital | Q14716129 | ||
Decatur Memorial Hospital | Q22033932 | ||
Mayo Clinic | Q1130172 | ||
Tulane University | Q1193547 | ||
Fred Hutchinson Cancer Research Center | Q1452369 | ||
Rush University Medical Center | Q1535116 | ||
Denver Health Medical Center | Q3023367 | ||
AdventHealth Porter | Q3145247 | ||
Bryn Mawr Hospital | Q4980899 | ||
Hennepin County Medical Center | Q5714832 | ||
Long Island Jewish Medical Center | Q6672700 | ||
Loyola University Medical Center | Q6694611 | ||
Medical College of Wisconsin | Q6806307 | ||
Medical University of South Carolina | Q6806451 | ||
Memorial Medical Center | Q6815474 | ||
Munson Medical Center | Q6936903 | ||
MetroHealth Medical Center | Q30254005 | ||
UNM Los Lunas | Q30258334 | ||
21st Century Oncology (United States) | Q30269404 | ||
Sky Ridge Medical Center | Q30270451 | ||
Iowa Methodist Medical Center | Q30280192 | ||
Jewish Hospital | Q30280293 | ||
Mercy Medical Center | Q30281132 | ||
Comprehensive Cancer Centers of Nevada | Q30286943 | ||
West Michigan Cancer Center | Q30289179 | ||
Colorado Blood Cancer Institute | Q43896855 | ||
Southern Illinois University Edwardsville | Q519349 | ||
Loma Linda University | Q1057447 | ||
P859 | sponsor | National Cancer Institute | Q664846 |
P580 | start time | 2017-08-10 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma |
Search more.